The Latest SPAC News and Rumors: September 19, 2022

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News:  DWAC fails to pay proxy solicitors, and Ocean Biomedical discovers new therapy that can potentially kill cancerous cells

Trump SPAC fails to pay proxy firm despite tough hunt for votes, Financial Times reports

Executives behind a SPAC Digital World Acquisition Corp (NASDAQ:DWAC) that plans to take Donald Trump’s media business public have failed to pay their proxy solicitors, The Financial Times reported on Saturday.

Digital World Acquisition Corp, set up by Patrick Orlando, has not paid Saratoga Proxy Consulting for its work helping to rally shareholders, report said, citing people familiar with the matter.

Ocean Biomedical discovers new therapy that can potentially kill cancerous cells

Ocean Biomedical and Aesther Healthcare Acquisition Corp. announced the discovery of a therapy that could potentially kill glioblastoma and melanoma cells – two types of cancerous cells – and block the spread of these cells to the lungs.

The company discovered antibodies that can target both CHI3L1, a regulator of a series of cancer-causing pathways, and ICPI, immune checkpoint inhibitors.

The Providence-based biopharma company recently announced it has entered a merger agreement with special purpose acquisition company Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA), which is expected to be complete by the end of 2022. Ocean Biomedical will then become a subsidiary of Aesther Healthcare Acquisition Corp. and the combined company will be renamed Ocean Biomedical Inc.